ArticleFrontiers in cell and developmental biology2021

Deciphering the Mechanism of Gilteritinib Overcoming Lorlatinib Resistance to the Double Mutant I1171N/F1174I in Anaplastic Lymphoma Kinase.

Shuai Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.